AAREYDRUGS.NSAAREYDRUGS.NSNSE
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | -33.85% |
| Q3 2025 | -25.22% |
| Q2 2025 | -57.68% |
| Q1 2025 | 425.16% |
| Q4 2024 | -78.43% |
| Q3 2024 | 97.84% |
| Q2 2024 | 172.42% |
| Q1 2024 | -406.67% |
| Q4 2023 | -14.06% |
| Q3 2023 | -62.34% |
| Q2 2023 | -19.66% |
| Q1 2023 | 226.96% |
| Q4 2022 | 0.99% |
| Q3 2022 | -10.76% |
| Q2 2022 | 111.93% |
| Q1 2022 | -307.47% |
| Q4 2021 | 14.58% |
| Q3 2021 | -4.17% |
| Q2 2021 | 141.63% |
| Q1 2021 | -232.56% |
| Q4 2020 | 197.09% |
| Q3 2020 | 72.48% |
| Q2 2020 | 113.21% |
| Q1 2020 | -312.26% |
| Q4 2019 | 58.35% |
| Q3 2019 | -28.41% |
| Q2 2019 | 149.22% |
| Q1 2019 | -368.86% |
| Q4 2018 | -22.89% |
| Q3 2018 | 72.51% |
| Q2 2018 | -60.01% |
| Q1 2018 | 194.13% |
| Q4 2017 | 0.49% |
| Q3 2017 | -28.81% |
| Q2 2017 | -26.90% |
| Q1 2017 | 139.89% |
| Q4 2016 | -40.14% |
| Q3 2016 | 32.29% |
| Q2 2016 | 28.04% |
| Q1 2016 | -1.18% |